Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bipolar Disorder Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Bipolar I Disorder
1.2.3 Bipolar II Disorder
1.2.4 Cyclothymic Disorder
1.3 Market by Application
1.3.1 Global Bipolar Disorder Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Mood Stabilizers
1.3.3 Anticonvulsants
1.3.4 Antipsychotic drugs
1.3.5 Antidepressant drugs
1.3.6 Antianxiety drugs
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bipolar Disorder Market Perspective (2018-2033)
2.2 Bipolar Disorder Growth Trends by Region
2.2.1 Global Bipolar Disorder Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Bipolar Disorder Historic Market Size by Region (2018-2023)
2.2.3 Bipolar Disorder Forecasted Market Size by Region (2024-2033)
2.3 Bipolar Disorder Market Dynamics
2.3.1 Bipolar Disorder Industry Trends
2.3.2 Bipolar Disorder Market Drivers
2.3.3 Bipolar Disorder Market Challenges
2.3.4 Bipolar Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorder Players by Revenue
3.1.1 Global Top Bipolar Disorder Players by Revenue (2018-2023)
3.1.2 Global Bipolar Disorder Revenue Market Share by Players (2018-2023)
3.2 Global Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorder Revenue
3.4 Global Bipolar Disorder Market Concentration Ratio
3.4.1 Global Bipolar Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorder Revenue in 2022
3.5 Bipolar Disorder Key Players Head office and Area Served
3.6 Key Players Bipolar Disorder Product Solution and Service
3.7 Date of Enter into Bipolar Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bipolar Disorder Breakdown Data by Type
4.1 Global Bipolar Disorder Historic Market Size by Type (2018-2023)
4.2 Global Bipolar Disorder Forecasted Market Size by Type (2024-2033)
5 Bipolar Disorder Breakdown Data by Application
5.1 Global Bipolar Disorder Historic Market Size by Application (2018-2023)
5.2 Global Bipolar Disorder Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Bipolar Disorder Market Size (2018-2033)
6.2 North America Bipolar Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Bipolar Disorder Market Size by Country (2018-2023)
6.4 North America Bipolar Disorder Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bipolar Disorder Market Size (2018-2033)
7.2 Europe Bipolar Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Bipolar Disorder Market Size by Country (2018-2023)
7.4 Europe Bipolar Disorder Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bipolar Disorder Market Size (2018-2033)
8.2 Asia-Pacific Bipolar Disorder Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Bipolar Disorder Market Size by Region (2018-2023)
8.4 Asia-Pacific Bipolar Disorder Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bipolar Disorder Market Size (2018-2033)
9.2 Latin America Bipolar Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Bipolar Disorder Market Size by Country (2018-2023)
9.4 Latin America Bipolar Disorder Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bipolar Disorder Market Size (2018-2033)
10.2 Middle East & Africa Bipolar Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Bipolar Disorder Market Size by Country (2018-2023)
10.4 Middle East & Africa Bipolar Disorder Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Glaxo SmithKline (GSK)
11.1.1 Glaxo SmithKline (GSK) Company Detail
11.1.2 Glaxo SmithKline (GSK) Business Overview
11.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Introduction
11.1.4 Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2018-2023)
11.1.5 Glaxo SmithKline (GSK) Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Bipolar Disorder Introduction
11.2.4 Pfizer Inc. Revenue in Bipolar Disorder Business (2018-2023)
11.2.5 Pfizer Inc. Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Detail
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Bipolar Disorder Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2018-2023)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bipolar Disorder Introduction
11.4.4 Eli Lilly Revenue in Bipolar Disorder Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Allergan Plc.
11.5.1 Allergan Plc. Company Detail
11.5.2 Allergan Plc. Business Overview
11.5.3 Allergan Plc. Bipolar Disorder Introduction
11.5.4 Allergan Plc. Revenue in Bipolar Disorder Business (2018-2023)
11.5.5 Allergan Plc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Bipolar Disorder Introduction
11.6.4 Novartis AG Revenue in Bipolar Disorder Business (2018-2023)
11.6.5 Novartis AG Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Detail
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Bipolar Disorder Introduction
11.7.4 AbbVie Inc. Revenue in Bipolar Disorder Business (2018-2023)
11.7.5 AbbVie Inc. Recent Development
11.8 Otsuka Holdings Ltd
11.8.1 Otsuka Holdings Ltd Company Detail
11.8.2 Otsuka Holdings Ltd Business Overview
11.8.3 Otsuka Holdings Ltd Bipolar Disorder Introduction
11.8.4 Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2018-2023)
11.8.5 Otsuka Holdings Ltd Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Bipolar Disorder Introduction
11.9.4 AstraZeneca Revenue in Bipolar Disorder Business (2018-2023)
11.9.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Bipolar Disorder Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Bipolar I Disorder
Table 3. Key Players of Bipolar II Disorder
Table 4. Key Players of Cyclothymic Disorder
Table 5. Global Bipolar Disorder Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Bipolar Disorder Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Bipolar Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Bipolar Disorder Market Share by Region (2018-2023)
Table 9. Global Bipolar Disorder Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Bipolar Disorder Market Share by Region (2024-2033)
Table 11. Bipolar Disorder Market Trends
Table 12. Bipolar Disorder Market Drivers
Table 13. Bipolar Disorder Market Challenges
Table 14. Bipolar Disorder Market Restraints
Table 15. Global Bipolar Disorder Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Bipolar Disorder Market Share by Players (2018-2023)
Table 17. Global Top Bipolar Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2022)
Table 18. Ranking of Global Top Bipolar Disorder Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Bipolar Disorder Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bipolar Disorder Product Solution and Service
Table 22. Date of Enter into Bipolar Disorder Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bipolar Disorder Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Bipolar Disorder Revenue Market Share by Type (2018-2023)
Table 26. Global Bipolar Disorder Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Bipolar Disorder Revenue Market Share by Type (2024-2033)
Table 28. Global Bipolar Disorder Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Bipolar Disorder Revenue Market Share by Application (2018-2023)
Table 30. Global Bipolar Disorder Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Bipolar Disorder Revenue Market Share by Application (2024-2033)
Table 32. North America Bipolar Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Bipolar Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Bipolar Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Bipolar Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Bipolar Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Bipolar Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Bipolar Disorder Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Bipolar Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Bipolar Disorder Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Bipolar Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Bipolar Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Bipolar Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Bipolar Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Bipolar Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Bipolar Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 47. Glaxo SmithKline (GSK) Company Detail
Table 48. Glaxo SmithKline (GSK) Business Overview
Table 49. Glaxo SmithKline (GSK) Bipolar Disorder Product
Table 50. Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2018-2023) & (US$ Million)
Table 51. Glaxo SmithKline (GSK) Recent Development
Table 52. Pfizer Inc. Company Detail
Table 53. Pfizer Inc. Business Overview
Table 54. Pfizer Inc. Bipolar Disorder Product
Table 55. Pfizer Inc. Revenue in Bipolar Disorder Business (2018-2023) & (US$ Million)
Table 56. Pfizer Inc. Recent Development
Table 57. Janssen Pharmaceuticals Company Detail
Table 58. Janssen Pharmaceuticals Business Overview
Table 59. Janssen Pharmaceuticals Bipolar Disorder Product
Table 60. Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2018-2023) & (US$ Million)
Table 61. Janssen Pharmaceuticals Recent Development
Table 62. Eli Lilly Company Detail
Table 63. Eli Lilly Business Overview
Table 64. Eli Lilly Bipolar Disorder Product
Table 65. Eli Lilly Revenue in Bipolar Disorder Business (2018-2023) & (US$ Million)
Table 66. Eli Lilly Recent Development
Table 67. Allergan Plc. Company Detail
Table 68. Allergan Plc. Business Overview
Table 69. Allergan Plc. Bipolar Disorder Product
Table 70. Allergan Plc. Revenue in Bipolar Disorder Business (2018-2023) & (US$ Million)
Table 71. Allergan Plc. Recent Development
Table 72. Novartis AG Company Detail
Table 73. Novartis AG Business Overview
Table 74. Novartis AG Bipolar Disorder Product
Table 75. Novartis AG Revenue in Bipolar Disorder Business (2018-2023) & (US$ Million)
Table 76. Novartis AG Recent Development
Table 77. AbbVie Inc. Company Detail
Table 78. AbbVie Inc. Business Overview
Table 79. AbbVie Inc. Bipolar Disorder Product
Table 80. AbbVie Inc. Revenue in Bipolar Disorder Business (2018-2023) & (US$ Million)
Table 81. AbbVie Inc. Recent Development
Table 82. Otsuka Holdings Ltd Company Detail
Table 83. Otsuka Holdings Ltd Business Overview
Table 84. Otsuka Holdings Ltd Bipolar Disorder Product
Table 85. Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2018-2023) & (US$ Million)
Table 86. Otsuka Holdings Ltd Recent Development
Table 87. AstraZeneca Company Detail
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Bipolar Disorder Product
Table 90. AstraZeneca Revenue in Bipolar Disorder Business (2018-2023) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bipolar Disorder Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Bipolar Disorder Market Share by Type: 2022 VS 2033
Figure 3. Bipolar I Disorder Features
Figure 4. Bipolar II Disorder Features
Figure 5. Cyclothymic Disorder Features
Figure 6. Global Bipolar Disorder Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Bipolar Disorder Market Share by Application: 2022 VS 2033
Figure 8. Mood Stabilizers Case Studies
Figure 9. Anticonvulsants Case Studies
Figure 10. Antipsychotic drugs Case Studies
Figure 11. Antidepressant drugs Case Studies
Figure 12. Antianxiety drugs Case Studies
Figure 13. Others Case Studies
Figure 14. Bipolar Disorder Report Years Considered
Figure 15. Global Bipolar Disorder Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Bipolar Disorder Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Bipolar Disorder Market Share by Region: 2022 VS 2033
Figure 18. Global Bipolar Disorder Market Share by Players in 2022
Figure 19. Global Top Bipolar Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Bipolar Disorder Revenue in 2022
Figure 21. North America Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Bipolar Disorder Market Share by Country (2018-2033)
Figure 23. United States Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Bipolar Disorder Market Share by Country (2018-2033)
Figure 27. Germany Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Bipolar Disorder Market Share by Region (2018-2033)
Figure 35. China Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Bipolar Disorder Market Share by Country (2018-2033)
Figure 43. Mexico Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Bipolar Disorder Market Share by Country (2018-2033)
Figure 47. Turkey Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Bipolar Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Glaxo SmithKline (GSK) Revenue Growth Rate in Bipolar Disorder Business (2018-2023)
Figure 50. Pfizer Inc. Revenue Growth Rate in Bipolar Disorder Business (2018-2023)
Figure 51. Janssen Pharmaceuticals Revenue Growth Rate in Bipolar Disorder Business (2018-2023)
Figure 52. Eli Lilly Revenue Growth Rate in Bipolar Disorder Business (2018-2023)
Figure 53. Allergan Plc. Revenue Growth Rate in Bipolar Disorder Business (2018-2023)
Figure 54. Novartis AG Revenue Growth Rate in Bipolar Disorder Business (2018-2023)
Figure 55. AbbVie Inc. Revenue Growth Rate in Bipolar Disorder Business (2018-2023)
Figure 56. Otsuka Holdings Ltd Revenue Growth Rate in Bipolar Disorder Business (2018-2023)
Figure 57. AstraZeneca Revenue Growth Rate in Bipolar Disorder Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed